Abstract
dl-Sarkomycin (2-methylenecyclopentanone-3-carboxylic acid) was synthesized in a four-stage process starting from ethyl cyclopentanone-3-carboxylate, prepared by Kay’s procedure. Namely, ethyl cyclopentanone-3-carboxylate was converted into ethyl 2-(dialkylaminomethyl)-cyclopentanone-3-carboxylate and thence to ethyl 2-methylenecyclopentanone-3-carboxylate. The ester was hydrolyzed to 2-methylenecyclopentanone-3-carboxylic acid with diluted hydrochloric acid. The final product was a pale yellow oil and was effective in inhibiting the growth of Ehrlich carcinoma of mice.

This publication has 1 reference indexed in Scilit: